---
schema_version: "secwatch.filing_event.v1"
accession: "0000897101-23-000086"
form_type: "8-K"
ticker: "ELMD"
cik: "0001488917"
company_name: "Electromed, Inc."
filed_at: "2023-02-14T23:59:59+00:00"
generated_at: "2026-06-19T13:38:50.331195+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Electromed reports record Q2 revenue of $11.7M (+15% YoY); CEO Skarvan to retire July 1, 2023

## Summary
- Q2 FY2023 net revenue of $11.7M (record), up 15% YoY; net income of $977k ($0.11 diluted) vs $838k ($0.10).
- Homecare revenue up 14% to $10.7M; operating income $1.3M vs $1.1M.
- CEO Kathleen Skarvan to retire on/about July 1, 2023; will become Board Chair; search for successor underway.
- Cash $6.9M; next-gen SmartVest Clearway FDA-cleared; Brad Nagel appointed CFO in Nov 2022.

## SEC filing metadata
- accession: 0000897101-23-000086
- form_type: 8-K
- ticker: ELMD
- cik: 0001488917
- company_name: Electromed, Inc.
- filed_at: 2023-02-14T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1488917/000089710123000086/0000897101-23-000086-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1488917/000089710123000086/elmd230175_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000897101-23-000086
- JSON: https://secwatch.observer/filing/0000897101-23-000086.json
- Plain text: https://secwatch.observer/filing/0000897101-23-000086.txt

## Key facts
- Earnings Releases
  Electromed, Inc. reported the three months ended December 31, 2022 results: revenue $11.7 million, net income $977,000, EPS $0.11 per diluted share.
  - Period: the three months ended December 31, 2022
  - Revenue: $11.7 million
  - Net income: $977,000
  - EPS: $0.11 per diluted share
  - Result: reported results
  source text: innovative airway clearance technologies, today announced financial results for the three months ended December 31, 2022 (“Q2 FY 2023”). Q2 FY 2023 Highlights ● Net revenue was $11.7 million for the three months ended December 31, 2022, a quarterly record and a 15% increase from $10.2 million for the three months ended December 31, 2021 (“Q2 FY 2022”) ●
  evidence_url: https://www.sec.gov/Archives/edgar/data/1488917/000089710123000086/0000897101-23-000086-index.htm
- Executive change
  Kathleen S. Skarvan departed as President and Chief Executive Officer at Electromed, Inc..
  - Action: retire
  - Role: President and Chief Executive Officer
  source text: Kathleen S. Skarvan, the President and Chief Executive Officer of the Company, notified the Company of her intention to retire from the Company effective on or about July 1, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1488917/000089710123000086/0000897101-23-000086-index.htm
- Executive change
  Kathleen S. Skarvan was appointed as Chair of the Board at Electromed, Inc..
  - Action: appointed
  - Role: Chair of the Board
  source text: Following the Retirement Date, Ms. Skarvan is expected to serve as a non-employee member and Chair of the Board
  evidence_url: https://www.sec.gov/Archives/edgar/data/1488917/000089710123000086/0000897101-23-000086-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.